Resource utilization and costs of age-related macular degeneration.
about
Cost-effectiveness of ranibizumab for neovascular age-related macular degenerationCost-effectiveness of smoking cessation to prevent age-related macular degeneration.Single food focus dietary guidance: lessons learned from an economic analysis of egg consumptionEconomic Evaluation of a Home-Based Age-Related Macular Degeneration Monitoring System.
P2860
Resource utilization and costs of age-related macular degeneration.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Resource utilization and costs of age-related macular degeneration.
@ast
Resource utilization and costs of age-related macular degeneration.
@en
Resource utilization and costs of age-related macular degeneration.
@nl
type
label
Resource utilization and costs of age-related macular degeneration.
@ast
Resource utilization and costs of age-related macular degeneration.
@en
Resource utilization and costs of age-related macular degeneration.
@nl
prefLabel
Resource utilization and costs of age-related macular degeneration.
@ast
Resource utilization and costs of age-related macular degeneration.
@en
Resource utilization and costs of age-related macular degeneration.
@nl
P2093
P2860
P1476
Resource utilization and costs of age-related macular degeneration.
@en
P2093
David Covert
Jordana K Schmier
Krithika Venkataraman
Michael T Halpern
P2860
P577
2006-01-01T00:00:00Z